One dose of 1ml contains:
|Influenza A/eq/Ohio/0s [H3N8] recombinant Canarypox virus (vCP2242)||> 5.3 log10FAID50 *|
|Influenza A/eq/Richmond/1/07 [H3N8] recombinant Canarypox virus (vCP3011)||> 5.3 log10FAID50 *|
|Clostridium tetani toxoid||> 30 IU**|
* vCP content checked by global FAID50 (fluorescent assay infectious dose 50%) and qPCR ratio between vCP.
** antitoxic antibody titre induced after repeated vaccination in guinea pig sera according to Ph.Eur.
The vaccine strains vCP2242 and vCP3011 are recombinant canarypox viruses expressing the haemagglutinin HA gene from the equine influenza virus strains A/eq/Ohio/03 (American strain, Florida sublineage clade 1) and A/eq/Richmond/1/07 (American strain, Florida sublineage clade 2), respectively. After inoculation, the viruses do not multiply in the horse but express the protective proteins. As a consequence, these components induce immunity against equine influenza virus [H3N8].